R
Roquefort Therapeutics PLC
LSE:ROQ
Roquefort Therapeutics PLC
LSE:ROQ
Price:
8.5
GBX
-8.11%
Market Closed
Market Cap:
£1.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Roquefort Therapeutics PLC
LSE:ROQ
|
UK |
|
N
|
Nepon Inc
TSE:7985
|
JP |
Income Statement
Earnings Waterfall
Roquefort Therapeutics PLC
Roquefort Therapeutics PLC
Income Statement
Roquefort Therapeutics PLC
Roquefort Therapeutics PLC
Currency: GBP
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||
| Cost of Revenue |
(0)
|
0
|
0
|
(0)
|
|
| Gross Profit |
(0)
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
|
| Operating Income | |||||
| Operating Expenses |
(1)
|
(2)
|
(2)
|
(1)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(2)
|
(1)
|
|
| Research & Development |
0
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
0
|
0
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
(0)
|
0
|
|
| Operating Income |
(1)
N/A
|
(2)
-220%
|
(2)
-18%
|
(1)
+42%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
0
|
0
|
0
|
(0)
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
(1)
N/A
|
(2)
-78%
|
(2)
-18%
|
(1)
+37%
|
|
| Net Income | |||||
| Tax Provision |
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(1)
|
(2)
|
(2)
|
(1)
|
|
| Net Income (Common) |
(1)
N/A
|
(2)
-76%
|
(2)
-8%
|
(1)
+44%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
